Literature DB >> 24649066

Plasma exchange in small intestinal transplantation between ABO-incompatible individuals: A case report.

Qiuhui Zhang1, Xingbin Hu1, Aijun Xia1, Jing Yi1, Qunxing An1, Xianqing Zhang1.   

Abstract

The aim of this study was to investigate the application of plasma exchange in small intestinal transplantation between ABO blood type-incompatible patients. A small intestinal transplantation case between ABO-incompatible individuals is hereby presented and analyzed. The main treatment included plasma exchange, splenectomy and immunosuppression. The patient undergoing small intestinal transplantation exhibited stable vital signs. A mild acute rejection reaction developed ~2 weeks after the surgery, which the patient successfully overcame. The subsequent colonoscopy and pathological examination revealed no signs of acute rejection. In conclusion, plasma exchange in combination with anti-immune rejection therapy proved to be an effective scheme for the management of small intestinal transplantation between ABO-incompatible patients.

Entities:  

Keywords:  ABO-incompatible; desensitization; intestinal transplantation; plasma exchange

Year:  2013        PMID： 24649066      PMCID： PMC3916975          DOI： 10.3892/br.2013.177

Source DB:  PubMed          Journal:  Biomed Rep        ISSN： 2049-9434


  10 in total

1.  Infectious complications following living-related small bowel transplantation in adults.

Authors:  L Cicalese; P Sileri; M Asolati; C Rastellini; H Abcarian; E Benedetti
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

Review 2.  The current status of small bowel transplantation in the UK and internationally.

Authors:  S J Middleton; N V Jamieson
Journal:  Gut       Date:  2005-11       Impact factor: 23.059

3.  Nutritional management of intestinal transplant recipients.

Authors:  J Reyes; A G Tzakis; S Todo; B Nour; A Casavilla; K Abu-Elmagd; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

4.  Use of quantitative PCR to predict onset of Epstein-Barr viral infection and post-transplant lymphoproliferative disease after intestinal transplantation in children.

Authors:  M Green; J Reyes; N Jabbour; E Yunis; P Putnam; S Todo; D Rowe
Journal:  Transplant Proc       Date:  1996-10       Impact factor: 1.066

5.  Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal transplant recipients: a randomized phase II study.

Authors:  Lionel Rostaing; Pablo Massari; Valter Duro Garcia; Eduardo Mancilla-Urrea; Georgy Nainan; Maria del Carmen Rial; Steven Steinberg; Flavio Vincenti; Rebecca Shi; Greg Di Russo; Dolca Thomas; Josep Grinyó
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-04       Impact factor: 8.237

6.  Infectious enteritis after intestinal transplantation: incidence, timing, and outcome.

Authors:  David Ziring; Robert Tran; Susan Edelstein; Sue V McDiarmid; Nupoor Gajjar; Galen Cortina; Jorge Vargas; John F Renz; James D Cherry; Paul Krogstad; Marjorie Miller; Ronald W Busuttil; Douglas G Farmer
Journal:  Transplantation       Date:  2005-03-27       Impact factor: 4.939

7.  Transplantation of the spleen: effect of splenic allograft in human multivisceral transplantation.

Authors:  Tomoaki Kato; Andreas G Tzakis; Gennaro Selvaggi; Jeffrey J Gaynor; Hidenori Takahashi; James Mathew; Rolando Garcia-Morales; Erick Hernandez; Andre David; Seigo Nishida; David Levi; Jang Moon; Eddie Island; Gary Kleiner; Phillip Ruiz
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

8.  Subclinical rejection in the initial postoperative period in small intestinal transplantation: a negative influence on graft survival.

Authors:  Hidenori Takahashi; Tomoaki Kato; Gennaro Selvaggi; Seigo Nishida; Jeffrey J Gaynor; Victor Delacruz; Jang I Moon; David M Levi; Andreas G Tzakis; Phillip Ruiz
Journal:  Transplantation       Date:  2007-09-27       Impact factor: 4.939

9.  Six consecutive cases of successful adult ABO-incompatible living donor liver transplantation: a proposal for grading the severity of antibody-mediated rejection.

Authors:  Daisuke Morioka; Shinji Togo; Takafumi Kumamoto; Kazuhisa Takeda; Ken-ichi Matsuo; Yoshiaki Inayama; Shoji Yamanaka; Kuniya Tanaka; Itaru Endo; Jiro Maegawa; Hiroshi Shimada
Journal:  Transplantation       Date:  2008-01-27       Impact factor: 4.939

10.  Three years clinical experience with intestinal transplantation.

Authors:  K Abu-Elmagd; S Todo; A Tzakis; J Reyes; B Nour; H Furukawa; J J Fung; A Demetris; T E Starzl
Journal:  J Am Coll Surg       Date:  1994-10       Impact factor: 6.113
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.